Cargando…
Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling
BACKGROUND: Interleukin-6 (IL-6) is a multifunctional cytokine, which is involved in the regulation of differentiation and growth of certain types of tumor cells. Constitutive activation of Signal Transducer and Activator of Transcription 3 (STAT3) induced by IL-6 is frequently detected in liver can...
Autores principales: | Wang, Yina, Ma, Haiyan, Zhao, Chongqiang, Liu, Tianshu, Yan, Dan, Jou, David, Li, Huameng, Zhang, Cuntai, Lü, Jiagao, Li, Chenglong, Lin, Jiayuh, Li, Sheng, Lin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464902/ https://www.ncbi.nlm.nih.gov/pubmed/28430601 http://dx.doi.org/10.18632/oncotarget.16898 |
Ejemplares similares
-
Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma
por: Ma, Haiyan, et al.
Publicado: (2019) -
Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene
por: Huo, Shengqi, et al.
Publicado: (2021) -
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019) -
A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells
por: Zhao, Chongqiang, et al.
Publicado: (2016) -
Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019)